In focus · trending topic

EyeGate Pharmaceuticals

1 stories · following the connections

EyeGate Achieves 75% Enrollment in Pivotal Phase 3 Clinical Trial for Anterior Uveitis Triggering Milestone Payment

By Nasdaq OMXDec 18, 2017, 1:30 PM UTC